Loading
Vector Borne Infectious Diseases · Journal article
The Journal of Immunology · July 28, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is an experimental study in mice showing that adoptively transferred ovalbumin-specific T cells can proliferate in response to engineered B. burgdorferi expressing the OVA epitope, and that in vitro reprogramming of these T cells toward alternative helper polarizations reduces bacterial burden and immunopathology. The findings are proof-of-concept only and do not directly address human Lyme disease prevention or treatment.
Experimental immunology study with adoptive T cell transfer in mice. OT-II TCR transgenic mice infected with engineered B. burgdorferi; no human subjects described.. Intervention: Engineered B. burgdorferi expressing OVA epitope (Bb-OVA); adoptively transferred OVA-specific T cells; in vitro T cell reprogramming to alternative T-helper polarizations.. Compared with: Bb-control (non-OVA-expressing B. burgdorferi); natural infection-driven T cell polarization (no reprogramming)..
OVA-specific T cells proliferate during infection with Bb-OVA but not Bb-control in an antigen-specific manner Natural infection-driven polarization of OVA-specific T cells does not provide robust protection In vitro reprogramming of OVA-specific T cells to alternative T-helper polarizations before adoptive transfer reduces bacterial burden and immunopathology (carditis and arthritis) in vivo
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
While the study provides mechanistic insight into T cell dysfunction during B. burgdorferi infection, the findings are limited to an artificial mouse model and do not immediately inform clinical vaccine design or treatment strategies. Future work linking these mechanisms to natural human infection and protective immunity is needed.
Proof-of-concept study in a mouse model using engineered bacteria and adoptive T cell transfer, demonstrating that in vitro T cell reprogramming can reduce bacterial burden, but findings are not yet translatable to human Lyme disease prevention or treatment.
As stated by the source record.
While the study provides mechanistic insight into T cell dysfunction during B. burgdorferi infection, the findings are limited to an artificial mouse model and do not immediately inform clinical vaccine design or treatment strategies. Future work linking these mechanisms to natural human infection and protective immunity is needed.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
Abstract Introduction Despite decades of research into Borrelia burgdorferi immunopathogenesis, less is known about antigen-specific T cell responses to this bacterial pathogen than the role of antibodies. Studying antigen-specific T cell responses to B. burgdorferi has been challenging due to the relatively few immunological tools available. Methods To address this, we have engineered B. burgdorferi to express a well-characterized CD4+ T cell epitope from chicken ovalbumin (Bb-OVA). Using adoptively transferred OVA-specific T cells from OT-II TCR transgenic mice, we show that these OVA-specific T cells proliferate during infection in an antigen-specific manner in response to Bb-OVA but not Bb-control. Using a variety of markers, we have characterized these antigen-specific T cells during various stages of infection, and the sites to which OVA-specific cells migrate. Results While polarization of OVA- specific T cells driven by natural infection do not provide robust protection, we show that reprograming OVA-specific T cells in vitro to different T-helper polarizations before adoptive transfer can reduce bacterial burden and immunopathology in vivo. Conclusion Taken together, our data demonstrate that although T cells are misprogrammed during natural infection, one can overcome this by reprogramming T cells towards alternative polarizations to reduce burden and immunopathology (eg. carditis and arthritis). Understanding the basis of these mechanisms is key to well-informed vaccine design that, with the help of adjuvants which can polarize T cells towards different subsets, will elicit strong T cell responses to confer long-lasting protection. Funding Source n/a Topic Categories Microbial, Parasitic, and Fungal Immunology (MPF)
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.